Qingling Hua

1.2k total citations
18 papers, 565 citations indexed

About

Qingling Hua is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Qingling Hua has authored 18 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Biomedical Engineering. Recurrent topics in Qingling Hua's work include Advanced Chemical Sensor Technologies (6 papers), Olfactory and Sensory Function Studies (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Qingling Hua is often cited by papers focused on Advanced Chemical Sensor Technologies (6 papers), Olfactory and Sensory Function Studies (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Qingling Hua collaborates with scholars based in China, Israel and Spain. Qingling Hua's co-authors include Hu Liu, Hossam Haick, Yueyin Pan, Haitham Amal, Dayou Shi, Radu Ionescu, Lei Zhao, Tao� Zhang, Sihan Wu and Hu Liu and has published in prestigious journals such as Hepatology, Oncogene and International Journal of Cancer.

In The Last Decade

Qingling Hua

17 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingling Hua China 12 319 183 130 89 88 18 565
Alfred Haidenberger Germany 8 496 1.6× 126 0.7× 202 1.6× 197 2.2× 53 0.6× 23 695
Catherine Soderstrom United States 12 136 0.4× 282 1.5× 20 0.2× 43 0.5× 99 1.1× 17 670
Lungen Lu China 5 167 0.5× 128 0.7× 55 0.4× 26 0.3× 21 0.2× 7 386
Ana Rita Lima Portugal 12 155 0.5× 358 2.0× 19 0.1× 163 1.8× 15 0.2× 13 499
Harald Bartsch Germany 8 119 0.4× 199 1.1× 10 0.1× 20 0.2× 198 2.3× 15 451
Lingyi Xu China 13 57 0.2× 246 1.3× 31 0.2× 13 0.1× 113 1.3× 35 570
Yanyan Guo China 14 35 0.1× 316 1.7× 80 0.6× 26 0.3× 39 0.4× 27 524
Joachim G. Müller United States 16 42 0.1× 357 2.0× 15 0.1× 13 0.1× 52 0.6× 23 791
Yuhao Wang China 10 27 0.1× 228 1.2× 21 0.2× 12 0.1× 56 0.6× 38 401
Seok‐Won Hyung South Korea 13 31 0.1× 216 1.2× 15 0.1× 124 1.4× 62 0.7× 19 410

Countries citing papers authored by Qingling Hua

Since Specialization
Citations

This map shows the geographic impact of Qingling Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingling Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingling Hua more than expected).

Fields of papers citing papers by Qingling Hua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingling Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingling Hua. The network helps show where Qingling Hua may publish in the future.

Co-authorship network of co-authors of Qingling Hua

This figure shows the co-authorship network connecting the top 25 collaborators of Qingling Hua. A scholar is included among the top collaborators of Qingling Hua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingling Hua. Qingling Hua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Hua, Qingling, et al.. (2023). KIAA1199 promotes oxaliplatin resistance and epithelial mesenchymal transition of colorectal cancer via protein O-GlcNAcylation. Translational Oncology. 28. 101617–101617. 9 indexed citations
3.
Xu, Guojie, Lei Zhao, Qingling Hua, et al.. (2023). CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway. Cell Death and Disease. 14(2). 167–167. 13 indexed citations
4.
Zhang, Biying, Jiao Li, Qingling Hua, et al.. (2023). Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation. Journal for ImmunoTherapy of Cancer. 11(1). e005592–e005592. 27 indexed citations
5.
Wang, Haihong, Biying Zhang, Ruiqi Li, et al.. (2022). KIAA1199 drives immune suppression to promote colorectal cancer liver metastasis by modulating neutrophil infiltration. Hepatology. 76(4). 967–981. 55 indexed citations
6.
Hua, Qingling, Biying Zhang, Guojie Xu, et al.. (2021). CEMIP, a novel adaptor protein of OGT, promotes colorectal cancer metastasis through glutamine metabolic reprogramming via reciprocal regulation of β-catenin. Oncogene. 40(46). 6443–6455. 41 indexed citations
7.
Wu, Sihan, et al.. (2021). Volatile Organic Compounds in Human Exhaled Breath to Diagnose Gastrointestinal Cancer: A Meta-Analysis. Frontiers in Oncology. 11. 606915–606915. 50 indexed citations
8.
Chen, Jiayuan, Qingling Hua, Haihong Wang, et al.. (2021). Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer. BMC Cancer. 21(1). 853–853. 12 indexed citations
9.
Hua, Qingling, Dejun Zhang, Yunqiao Li, et al.. (2021). Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study. Frontiers in Oncology. 11. 658152–658152. 4 indexed citations
10.
Hua, Qingling, Guojie Xu, Lei Zhao, & Tao Zhang. (2021). Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis. Journal of Chemotherapy. 33(5). 319–327. 1 indexed citations
11.
Zhang, Zhengxiang, et al.. (2020). SNORA71A Promotes Colorectal Cancer Cell Proliferation, Migration, and Invasion. BioMed Research International. 2020(1). 8284576–8284576. 30 indexed citations
12.
Hua, Qingling, et al.. (2018). Detection of Volatile Organic Compounds in Exhaled Breath to Screen Lung Cancer: A Systematic Review. Future Oncology. 14(16). 1647–1662. 29 indexed citations
13.
Hua, Qingling, et al.. (2018). Volatile metabonomic profiling in urine to detect novel biomarkers for B‑cell non‑Hodgkin's lymphoma. Oncology Letters. 15(5). 7806–7816. 10 indexed citations
14.
Hua, Qingling, et al.. (2016). Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis. International Urology and Nephrology. 48(9). 1437–1443. 5 indexed citations
15.
Hua, Qingling, et al.. (2015). Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin’s lymphoma (B-NHL) chemotherapy: a meta-analysis. Journal of Chemotherapy. 27(6). 365–370. 18 indexed citations
16.
Barash, Orna, Wei Zhang, Jeffrey Mark Halpern, et al.. (2015). Differentiation between genetic mutations of breast cancer by breath volatolomics. Oncotarget. 6(42). 44864–44876. 74 indexed citations
17.
Amal, Haitham, Dayou Shi, Radu Ionescu, et al.. (2015). Assessment of Ovarian Cancer Conditions From Exhaled Breath. Obstetrical & Gynecological Survey. 70(2). 89–91. 75 indexed citations
18.
Amal, Haitham, Dayou Shi, Radu Ionescu, et al.. (2014). Assessment of ovarian cancer conditions from exhaled breath. International Journal of Cancer. 136(6). E614–22. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026